
Clinitech Laboratory Limited
listed
₹1.15LMin. investment
About Clinitech Laboratory Limited
Issue size
₹5.78Cr
IPO type
SME
Price range
₹96.00 – ₹96.00
Lot size
1200 shares
RHP/DRHP
Read
Price range₹96.00 – ₹96.00
IPO type
SME
Lot size1200 shares
Issue size₹5.78Cr
RHP/DRHP
Read
Checklist
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial
health at a glance and identify quality investment opportunities easily
About Clinitech Laboratory Limited Founded in 1990, Clinitech Laboratory Limited operates a network of eight diagnostic centers strategically located in Thane and Navi Mumbai, offering a comprehensive range of diagnostic and healthcare tests. Annually, they conduct more than 3 lakh tests in their NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs, equipped with advanced technology and high-end equipment. These tests span across various disciplines including Biochemistry, Immunology, Hematology, Molecular Biology, Serology, Microbiology, and Histopathology, enabling precise diagnosis and effective treatment planning. Clinical pathology forms the core of their services, focusing on the analysis of bodily fluids and tissues to diagnose diseases and conditions. Their laboratories perform crucial tests such as blood tests, urine analysis, and tissue biopsies, which are essential in understanding the underlying causes of symptoms and guiding healthcare decisions. Their team of clinical pathologists plays a pivotal role in interpreting test results and providing valuable insights to aid in patient care. Looking ahead, they anticipate potential competition from new entrants with established business networks, posing threats to their market share. Such competitors may leverage larger financial resources for enhanced marketing and service delivery capabilities. Despite these challenges, Clinictech Laboratory Limited is poised to uphold its leadership in diagnostic and healthcare services through strategic management practices, technological innovation, and a steadfast commitment to meeting the evolving needs of their clientele. As Clinitech Laboratory Limited prepares for its Initial Public Offering (IPO), the proceeds from the Fresh Issue will be allocated towards critical objectives: Expansion of Diagnostic Centres; General Corporate Purposes
Frequently asked questions
How to invest in the IPO?
Investors can apply for the IPO through their Demat account via the stock exchange or through their broker.
What is the issue size of Clinitech Laboratory Limited ?
The issue size of the Clinitech Laboratory Limited is 5.78 Cr.
What is 'pre-apply' for Clinitech Laboratory Limited ?
Pre-applying for an IPO allows you to submit your application before the official subscription period begins.
Which exchanges will Clinitech Laboratory Limited shares list on?
The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.
Timeline
- Bidding starts25 Jul 2024
- Bidding ends29 Jul 2024
- Allotment finalisation27 Jul 2024
- Release of funds31 Jul 2024
- Demat transfer30 Jul 2024
- Listing1 Aug 2024